Targeting anaplastic lymphoma kinase in neuroblastoma

Over the last decade, anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase (RTK), has been identified as a fusion partner in a diverse variety of translocation events resulting in oncogenic signaling in many different cancer types. In tumors where the full‐length ALK RTK itself is mutated, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Umapathy, Ganesh, Mendoza‐Garcia, Patricia, Hallberg, Bengt, Palmer, Ruth H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850425/
https://www.ncbi.nlm.nih.gov/pubmed/30803032
http://dx.doi.org/10.1111/apm.12940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850425/
https://www.ncbi.nlm.nih.gov/pubmed/30803032
http://dx.doi.org/10.1111/apm.12940

Ejemplares similares